Class Action

TheraFlu Emergen-C and TheraFlu Multi-Symptom Severe Cold

Class Action

TheraFlu Emergen-C and TheraFlu Multi-Symptom Severe Cold


Case Name (Date)

Cirrito et al. v. GSK Consumer Health, Inc.
23-cv-491, W.D.N.Y.
(June 2023)


Product/Service

TheraFlu Emergen-C and TheraFlu Multi-Symptom Severe Cold


Allegations

Misleadingly marketing products as if they treat symptoms of coughs and colds


Status

Pending



Class-Action Tracker


The Latest

Filters

Benefiber

Ad Alert

Benefiber

If you see a supplement marketed as “clinically proven,” pump your brakes.